Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.
Shimizu T, Miyake M, Nishimura N, Inoue K, Fujii K, Iemura Y, Ichikawa K, Omori C, Tomizawa M, Maesaka F, Oda Y, Miyamoto T, Sakamoto K, Kiba K, Tanaka M, Oyama N, Okajima E, Fujimoto K, Hori S, Morizawa Y, Gotoh D, Nakai Y, Torimoto K, Tanaka N, Fujimoto K. Shimizu T, et al. Among authors: iemura y. Cancers (Basel). 2022 Mar 29;14(7):1735. doi: 10.3390/cancers14071735. Cancers (Basel). 2022. PMID: 35406508 Free PMC article.
Effect of Gender Differences on Transplant Kidney Function.
Yoneda T, Iemura Y, Onishi K, Hori S, Nakai Y, Miyake M, Anai S, Torimoto K, Aoki K, Saka T, Tanaka N, Yoshida K, Fujimoto K. Yoneda T, et al. Among authors: iemura y. Transplant Proc. 2017 Jan-Feb;49(1):61-64. doi: 10.1016/j.transproceed.2016.10.015. Transplant Proc. 2017. PMID: 28104160
Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: A multi-institutional retrospective study.
Owari T, Miyake M, Nakai Y, Hori S, Tomizawa M, Ichikawa K, Shimizu T, Iida K, Samma S, Iemura Y, Momose H, Omori C, Otani T, Kuwada M, Hirao S, Oyama N, Nakagawa Y, Hayashi Y, Tanaka N, Fujimoto K. Owari T, et al. Among authors: iemura y. Int J Urol. 2019 Jun;26(6):630-637. doi: 10.1111/iju.13939. Epub 2019 Mar 18. Int J Urol. 2019. PMID: 30883931
Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab.
Shimizu T, Miyake M, Hori S, Ichikawa K, Omori C, Iemura Y, Owari T, Itami Y, Nakai Y, Anai S, Tomioka A, Tanaka N, Fujimoto K. Shimizu T, et al. Among authors: iemura y. Diagnostics (Basel). 2020 May 15;10(5):310. doi: 10.3390/diagnostics10050310. Diagnostics (Basel). 2020. PMID: 32429323 Free PMC article.
Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model.
Onishi K, Miyake M, Tatsumi Y, Hori S, Nakai Y, Onishi S, Iemura Y, Owari T, Itami Y, Iida K, Anai S, Tanaka N, Shimada K, Fujimoto K. Onishi K, et al. Among authors: iemura y. Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3743-3749. doi: 10.31557/APJCP.2020.21.12.3743. Asian Pac J Cancer Prev. 2020. PMID: 33369476 Free PMC article.
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy.
Owari T, Miyake M, Nakai Y, Tanaka N, Itami Y, Hirao S, Momose H, Nakagawa Y, Iida K, Maesaka F, Shimizu T, Iemura Y, Matsumoto Y, Kuwada M, Otani T, Otsuka K, Okajima E, Hosokawa Y, Okamura R, Fujimoto K. Owari T, et al. Among authors: iemura y. J Bone Oncol. 2020 Dec 13;26:100344. doi: 10.1016/j.jbo.2020.100344. eCollection 2021 Feb. J Bone Oncol. 2020. PMID: 33384916 Free PMC article.
39 results